Gene · 92521
Papers3,158
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,261 to 1,280 of 3,158
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PDBe-KB: collaboratively defining the biological context of structural data. | Nucleic Acids Res | 2022 | 34755867 | PubTator, text mining | PubMed |
| Identification of genotypic variants and its proteomic mutations of Brazilian SARS-CoV-2 isolates. | Virus Res | 2022 | 34740719 | PubTator, text mining | PubMed |
| Circular RNAs exhibit limited evidence for translation, or translation regulation of the mRNA counterpart in terminal hematopoiesis. | RNA | 2022 | 34732567 | PubTator, text mining | PubMed |
Rotaviral nonstructural protein 5 (NSP5) promotes proteasomal degradation of up-frameshift protein 1 (UPF1), a principal mediator of nonsense-mediated mRNA decay (NMD) pathway, to facilitate infection. | Cell Signal | 2022 | 34718106 | PubTator, text mining | PubMed |
| Identification of RET fusions in a Chinese multicancer retrospective analysis by next-generation sequencing. | Cancer Sci | 2022 | 34710947 | PubTator, text mining | PubMed |
| Viral Modulation of the DNA Damage Response and Innate Immunity: Two Sides of the Same Coin. | J Mol Biol | 2022 | 34695379 | PubTator, text mining | PubMed |
| Altered increase in STAT1 expression and phosphorylation in severe COVID-19. | Eur J Immunol | 2022 | 34676541 | PubTator, text mining | PubMed |
| An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity. | Cell Chem Biol | 2022 | 34672954 | PubTator, text mining | PubMed |
| Features of Pathobiology and Clinical Translation of Approved Treatments for Coronavirus Disease 2019. | Intervirology | 2022 | 34666335 | PubTator, text mining | PubMed |
| Design of SARS-CoV-2 PLpro Inhibitors for COVID-19 Antiviral Therapy Leveraging Binding Cooperativity. | J Med Chem | 2022 | 34665619 | PubTator, text mining | PubMed |
| Targeting autophagy with natural products to prevent SARS-CoV-2 infection. | J Tradit Complement Med | 2022 | 34664025 | PubTator, text mining | PubMed |
| Novel Molecules derived from 3-O-(6-galloylglucoside) inhibit Main Protease of SARS-CoV 2 In Silico. | Chem Zvesti | 2022 | 34629698 | PubTator, text mining | PubMed |
| Repurposing the antibacterial drugs for inhibition of SARS-CoV2-PLpro using molecular docking, MD simulation and binding energy calculation. | Mol Divers | 2022 | 34591234 | PubTator, text mining | PubMed |
| SARS-CoV-2 and its beta variant of concern infect human conjunctival epithelial cells and induce differential antiviral innate immune response. | Ocul Surf | 2022 | 34583089 | PubTator, text mining | PubMed |
| Evolution of the SARS-CoV-2 proteome in three dimensions (3D) during the first 6 months of the COVID-19 pandemic. | Proteins | 2022 | 34580920 | PubTator, text mining | PubMed |
| SARS-CoV-2 Mutations and their Viral Variants. | Cytokine Growth Factor Rev | 2022 | 34580015 | PubTator, text mining | PubMed |
| Mechanisms of Antiviral Immune Evasion of SARS-CoV-2. | J Mol Biol | 2022 | 34562466 | PubTator, text mining | PubMed |
| An overview of human proteins and genes involved in SARS-CoV-2 infection. | Gene | 2022 | 34530086 | PubTator, text mining | PubMed |
| The inducing of caspase and Bcl-2 pathway with royal jelly decreases the muscle tissue damage exposed with fluoride in rats. | Environ Sci Pollut Res Int | 2022 | 34528203 | PubTator, text mining | PubMed |
| Advancements in detection of SARS-CoV-2 infection for confronting COVID-19 pandemics. | Lab Invest | 2022 | 34497366 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92521/papers?page=64